Back to top
more

Medpace (MEDP)

(Delayed Data from NSDQ)

$396.65 USD

396.65
161,065

-0.60 (-0.15%)

Updated May 21, 2024 04:00 PM ET

After-Market: $396.07 -0.58 (-0.15%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1        

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value A Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 38% (94 out of 248)

Industry: Medical Services

Better trading starts here.

Zacks News

Medpace (MEDP) is a Great Momentum Stock: Should You Buy?

Does Medpace (MEDP) have what it takes to be a top stock pick for momentum investors? Let's find out.

Top Ranked Momentum Stocks to Buy for August 20th

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, August 20th.

Zacks Industry Outlook Highlights: Medpace Holdings, AMN Healthcare Services, LHC Group and Surgery Partners

Zacks Industry Outlook Highlights: Medpace Holdings, AMN Healthcare Services, LHC Group and Surgery Partners

The Zacks Analyst Blog Highlights: Houghton Mifflin Harcourt Company, CoreLogic, FTI Consulting, Artisan Partners Asset Management and Medpace Holdings

The Zacks Analyst Blog Highlights: Houghton Mifflin Harcourt Company, CoreLogic, FTI Consulting, Artisan Partners Asset Management and Medpace Holdings

Urmimala Biswas headshot

Near-Term Outlook Tepid for Medical Services Industry

This sector witnesses growing demand for telemedicine-focused online medical services amid the pandemic.

Tirthankar Chakraborty headshot

Service Side of US Economy is Up and Running: 5 Top Picks

The service sector index read 58.1% in July, a 17-month high. Lest we forget, a reading above 48.5% indicates expansion of the broader economy.

Bet on These 5 Low Leverage Stocks This Earnings Season

Debt is something that gives you the chills since it brings with it the burden of repayment with additional interest in the future. So investors should choose stocks prudently

3 Reasons Why Medpace (MEDP) Is a Great Growth Stock

Medpace (MEDP) possesses solid growth attributes, which could help it handily outperform the market.

Medpace (MEDP) Q2 Earnings and Revenues Top Estimates (Revised)

Medpace (MEDP) delivered earnings and revenue surprises of 61.90% and 13.50%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Medpace (MEDP) Q2 Earnings and Revenues Top Estimates

Medpace (MEDP) delivered earnings and revenue surprises of 52.38% and 13.50%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Is a Surprise Coming for Medpace (MEDP) This Earnings Season?

Medpace (MEDP) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Medpace (MEDP) Expected to Beat Earnings Estimates: Should You Buy?

Medpace (MEDP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Medpace (MEDP) Q1 Earnings Miss Estimates

Medpace (MEDP) delivered earnings and revenue surprises of -1.30% and 1.24%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Teladoc (TDOC) Up 49% Year to Date: Will the Rally Continue?

Teladoc (TDOC) benefits from its fast growing healthcare business and international expansion.

Company News for Feb 26, 2020

Companies In The News Are: HPQ, KEYS, MEDP, MIC.

Medpace (MEDP) Surpasses Q4 Earnings and Revenue Estimates

Medpace (MEDP) delivered earnings and revenue surprises of 13.33% and 3.51%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

Medpace (MEDP) Q3 Earnings Meet Estimates

Medpace (MEDP) delivered earnings and revenue surprises of 0.00% and -0.24%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Medpace (MEDP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Medpace (MEDP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Should Teladoc Worry About Amazon's Virtual Healthcare Move?

Teladoc (TDOC) might face increasing competition from Amazon in virtual healthcare space once the latter expands its presence.

The Zacks Analyst Blog Highlights: RH, PennyMac, Medpace, Mercury Systems and Lithia

The Zacks Analyst Blog Highlights: RH, PennyMac, Medpace, Mercury Systems and Lithia

Nalak Das headshot

5 Must-Buy Mid-Cap Stocks Amid Global Economic Fluctuations

Investment in mid-cap stocks is often recognized as a good portfolio diversification strategy during market fluctuations.

U.S. Private Sector Adds New Jobs: 5 Gainers

Nonfarm payroll reports show jobs addition in the private sector, these are five stocks to add to your portfolio.

Teladoc Gains on Growing Acceptance for TeleHealth Services

Teladoc's (TDOC) extensive ecosystem and infrastructure poise it well for long-term growth in the expanding telehealth industry.

Medpace (MEDP) Soars to 52-Week High, Time to Cash Out?

Medpace (MEDP) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.